Loading...
Uploaded by TheStreetTV on Aug 5, 2008
BioSante's drug for the treatment of female sexual dysfunction, LibiGel, is entering Phase III trials. The company's CEO explains what the drug would mean for the pharmaceutical sector.
Howto & Style
Standard YouTube License
yay!
yummyapple4u 2 years ago
Load more suggestions
yay!
yummyapple4u 2 years ago